BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32415644)

  • 1. Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
    Ribeiro M; Durand T; Roussel M; Feuvret L; Jacob J; Psimaras D; Noel G; Keller A; Bompaire F; Hoang-Xuan K; Bernier MO; Godefroy O; Ricard D
    J Neurooncol; 2020 Jun; 148(2):335-342. PubMed ID: 32415644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.
    Godefroy O; Fickl A; Roussel M; Auribault C; Bugnicourt JM; Lamy C; Canaple S; Petitnicolas G
    Stroke; 2011 Jun; 42(6):1712-6. PubMed ID: 21474808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
    Tian R; Guo Y; Ye P; Zhang C; Luo Y
    PLoS One; 2020; 15(1):e0227073. PubMed ID: 31917792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.
    Pike NA; Poulsen MK; Woo MA
    Nurs Res; 2017; 66(3):222-230. PubMed ID: 28448372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
    Tiffin-Richards FE; Costa AS; Holschbach B; Frank RD; Vassiliadou A; Krüger T; Kuckuck K; Gross T; Eitner F; Floege J; Schulz JB; Reetz K
    PLoS One; 2014; 9(10):e106700. PubMed ID: 25347578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the Montreal Cognitive Assessment (MoCA) as a screening tool for mild cognitive impairment in the population of Buenos Aires, Argentina].
    González Palau F; Berrios W; García Basalo MM; Ojea Quintana M; Fernández M; García Basalo MJ; Fernández MC; Cámpora N; Matusevich LD; Golimstok Á
    Vertex; 2018 Jul; XXIX(140):261-269. PubMed ID: 30778419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.
    Clarnette R; O'Caoimh R; Antony DN; Svendrovski A; Molloy DW
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):643-649. PubMed ID: 27427212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischaemic attack: a validation study.
    Zuo L; Dong Y; Zhu R; Jin Z; Li Z; Wang Y; Zhao X; Sachdev P; Zhang W; Wang Y
    BMJ Open; 2016 Jul; 6(7):e011310. PubMed ID: 27406642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Mild Cognitive Impairment Among Community-Dwelling African Americans Using the Montreal Cognitive Assessment.
    Rossetti HC; Smith EE; Hynan LS; Lacritz LH; Cullum CM; Van Wright A; Weiner MF
    Arch Clin Neuropsychol; 2019 Aug; 34(6):809-813. PubMed ID: 30517598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief screening for mild cognitive impairment in subcortical ischemic vascular disease: a comparison study of the Montreal Cognitive Assessment with the Mini-Mental State Examination.
    Xu Q; Cao WW; Mi JH; Yu L; Lin Y; Li YS
    Eur Neurol; 2014; 71(3-4):106-14. PubMed ID: 24335198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment.
    Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A
    J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke.
    Zietemann V; Georgakis MK; Dondaine T; Müller C; Mendyk AM; Kopczak A; Hénon H; Bombois S; Wollenweber FA; Bordet R; Dichgans M
    Neurology; 2018 Nov; 91(20):e1838-e1850. PubMed ID: 30333158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of MoCA Cutoff Score in Patients with Alcohol Use Disorders.
    Ewert V; Pelletier S; Alarcon R; Nalpas B; Donnadieu-Rigole H; Trouillet R; Perney P
    Alcohol Clin Exp Res; 2018 Feb; 42(2):403-412. PubMed ID: 29120490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
    Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
    Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls.
    Dautzenberg G; Lijmer J; Beekman A
    Int J Geriatr Psychiatry; 2020 Mar; 35(3):261-269. PubMed ID: 31650623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.
    Hagen E; Sømhovd M; Hesse M; Arnevik EA; Erga AH
    J Subst Abuse Treat; 2019 Feb; 97():21-27. PubMed ID: 30577896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of extent and pattern of neurocognitive functions in mild and moderate traumatic brain injury patients by using Montreal Cognitive Assessment (MoCA) score as a screening tool: An observational study from India.
    Panwar N; Purohit D; Deo Sinha V; Joshi M
    Asian J Psychiatr; 2019 Mar; 41():60-65. PubMed ID: 30396805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.